dabigatran has been researched along with Complications, Hematologic Pregnancy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksa, K; Bapat, P; Berger, H; Kedar, R; Koren, G; Lubetsky, A; Matlow, JN | 1 |
| Conard, J; Horellou, MH; Samama, MM | 1 |
2 other study(ies) available for dabigatran and Complications, Hematologic Pregnancy
| Article | Year |
|---|---|
Transfer of dabigatran and dabigatran etexilate mesylate across the dually perfused human placenta.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Female; Fetus; Humans; In Vitro Techniques; Maternal-Fetal Exchange; Perfusion; Placenta; Pregnancy; Pregnancy Complications, Hematologic; Prodrugs; Pyridines | 2014 |
[Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].
Topics: Abnormalities, Drug-Induced; Adult; Anticoagulants; Benzimidazoles; Blood Loss, Surgical; Cesarean Section; Contraindications; Dabigatran; Europe; Evidence-Based Medicine; Female; Fetus; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Infant, Newborn; Morpholines; Polysaccharides; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Pyridines; Rivaroxaban; Societies, Medical; Thiophenes; Thrombophilia; United States; Uterine Hemorrhage; Venous Thromboembolism; Warfarin | 2009 |